Truliant 02-020-11-0215Recalls & reported problems
Exactech, Inc. · Class 2 · Implant
All models of Truliant (414)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10885862314406), received between Jun 14, 2023 and Sep 30, 2024 — classified as 3 injuries.
The most frequently reported specific device problem is “Loosening of Implant Not Related to Bone-Ingrowth” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Loosening of Implant Not Related to Bone-Ingrowth3
- Lack of Effect1
Patient problems
- Failure of Implant2
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Loss of Range of Motion1
- Osteolysis1
- Scar Tissue1
- Swelling/ Edema1
- Synovitis1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjurySep 30, 2024Loosening of Implant Not Related to Bone-Ingrowth; Loosening of Implant Not Related to Bone-Ingrowth
LEGAL CASE ¿ USA (MDL NO. (B)(4)). PATIENT ID: (B)(6). RELATED (B)(4). AS REPORTED VIA LEGAL DOCUMENTATION THE PATIENT HAD A LEFT KNEE REPLACEMENT ON (B)(6) 2019. APPROXIMATELY 3 YEARS AND 2 MONTHS AFTER THE INITIAL PROCEDURE THE PATIENT HAD A LEFT KNEE REVISION ON (B)(6) 2023. THERE IS NO OTHER PATIENT DEMOGRAPHIC OR MEDICAL HISTORY AVAILABLE. THERE IS NO INFORMATION ON THE SURGICAL PROCEDURE OR PATIENT OUTCOME. THERE IS NO DEVICE RETURN. THERE ARE NO PHOTOS OR OTHER IMAGES OF THE DEVICE PROVIDED. NO ADDITIONAL INFORMATION IS AVAILABLE. 02-022-35-1509 - TRULIANT TIB IMP PS INSERT SZ 1.5, 9MM. SN: (B)(6). CONCOMITANT DEVICES: (B)(4) A10012 - GPS IMPLANT KIT V2. (B)(4) 02-012-60-1425 - TRU STEM EXT 14MM X 25MM. (B)(4) 02-020-11-0215 - TRULIANT PS CEM FEM PS CEM LEFT SZ 1.5. (B)(4) 02-022-45-1515 - TRULIANT TIB FIT TRAY CEM SZ 1.5F / 1.5T. (B)(4) 200-02-29 - THREE PEG PATELLA 29MM. (B)(4) 204-70-00 - TIBIAL STEM EXT. SCREW. THE PATIENT HAS FILED A SHORT-FORM COMPLAINT IN A MULTIDISTRICT LITIGATION TITLED IN RE: EXACTECH POLYETHYLENE ORTHOPEDIC PRODUCTS LIABILITY LITIGATION, MDL NO. (B)(4), AND PENDING IN THE EASTERN DISTRICT OF NEW YORK. PER THE TRANSFER ORDER CREATING THIS MULTIDIST
Patient problems: Osteolysis
MAUDE report 20332542 ↗InjurySep 18, 2023Loosening of Implant Not Related to Bone-Ingrowth; Loosening of Implant Not Related to Bone-Ingrowth
IT WAS REPORTED THAT THIS 63 Y/O FEMALE PATIENT'S LEFT KNEE WAS REVISED. THE INITIAL PROCEDURE THE IMPLANT BECAME GROSSLY LOOSE. PATIENT WAS REVISED TO A CC TRULIANT FEMORAL COMPONENT WITH A STEM. PATIENT WAS LAST KNOWN TO BE IN STABLE CONDITION FOLLOWING THE EVENT. NO OTHER PATIENT INFORMATION/MEDICAL HISTORY. PRODUCT NOT RETURNING - IMPLANT WAS DISCARDED DURING CLEANING OF INSTRUMENTS. X-RAY ATTACHED. UNABLE TO OBTAIN PHOTOS.
Patient problems: Failure of Implant
MAUDE report 17765347 ↗InjuryJun 14, 2023Loosening of Implant Not Related to Bone-Ingrowth; Lack of Effect; Loosening of Implant Not Related to Bone-Ingrowth; Lack of Effect
AS REPORTED VIA LEGAL DOCUMENTATION, THIS PATIENT HAD A LEFT TOTAL KNEE ARTHROPLASTY ON (B)(6) 2018. THEY SUBSEQUENTLY HAD LEFT KNEE REVISION ON (B)(6) 2022, APPROXIMATELY 3 YEARS 11 MONTHS AFTER THEIR INITIAL SURGERY. POSTOPERATIVE DIAGNOSIS: FAILED LEFT TOTAL KNEE ARTHROPLASTY SECONDARY TO ASEPTIC LOOSENING OF THE FEMORAL COMPONENT AND A RECALLED TIBIAL INSERT. RADIOGRAPHS DID NOT SHOW ANY OBVIOUS SIGNS OF WEAR OR LOOSENING. THE PATIENT HAD SIGNIFICANT SCAR TISSUE WITHIN THE JOINT AND SOME SYNOVITIS, BUT NO SIGNS OF INFECTION OR PURULENCE. THE PATELLAR BUTTON WAS FOUND TO BE WELL FIXED AND IN GOOD CONDITION. UPON REMOVAL OF THE INSERT, THERE WERE NO SIGNS OF WEAR OR DAMAGE TO THE INSERT. THERE IS NO OTHER PATIENT DEMOGRAPHIC OR MEDICAL HISTORY AVAILABLE. THERE IS NO DEVICE RETURN. THERE ARE NO PHOTOS OR OTHER IMAGES OF THE DEVICE PROVIDED. NO ADDITIONAL INFORMATION IS AVAILABLE.
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Failure of Implant; Loss of Range of Motion; Scar Tissue; Swelling/ Edema; Synovitis
MAUDE report 17130934 ↗
Other Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer devices
- ATTUNE 1506-00-005Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER589 reports
- ATTUNE 1506-00-004Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER580 reports
- JOURNEY 74012812Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER502 reports
- JOURNEY 74011856Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER438 reports
- PERSONA™ 42-5099-094-00Zimmer, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER406 reports
- JOURNEY 74011857Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER388 reports
- ATTUNE 1506-00-007Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER288 reports
- ATTUNE 1506-00-003Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER271 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page